Network

BE.Amycon is a collaborative initiative spearheaded by a consortium of esteemed institutions including VIB, KULeuven, UZLeuven, UGent and UZGent. Together, our partners bring diverse expertise in clinical care, research, and innovation, underscoring our commitment to tackling amyloidosis comprehensively. 

As we continue to build and develop our website and initiatives, we invite you to join us on this journey toward a brighter future for amyloidosis research, treatment, and patient care.

Stay tuned for updates and exciting developments as we work together toward making a meaningful impact on amyloidosis in Belgium and beyond.